Clinical Trial

High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)

Study acronym: HIAIM
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate if high-intensive training can mobilize and activate the immune system, and thereby enhance the effect of the conventional treatment of lung cancer patients. An important aspect of this study will investigate if the presence of various proteins and cells in blood and tumor biopsies can verify or predict the effect of the high-intensive training. In this clinical trial, patients with lung cancer will combine their conventional therapy with a six-week exercise program.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-02-07; most recent amendment 2025-03-12.
Status change: Recruiting → Active, Not Recruiting 2025-03-12
Status change: Not Yet Recruiting → Recruiting 2020-09-18
Trial Details
NCT Number NCT04263467
Lead Sponsor Herlev Hospital
Conditions Cancer, Cancer of Lung
Enrollment 54 participants
Start Date 2020-08-17
Primary Completion 2024-01-22 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-17